DELAWARE
|
001-34079
|
11-3516358
|
(State or other jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
15245 Shady Grove Road, Suite 455
Rockville, MD
|
20850
|
(Address of principal executive offices)
|
(Zip Code)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
99.1
|
Rexahn Pharmaceuticals, Inc. slides for investor and other meetings, dated January 14, 2014.
|
REXAHN PHARMACEUTICALS, INC.
|
|||
Date: January 14, 2014
|
/s/ Tae Heum Jeong
|
||
Tae Heum Jeong
|
|||
Senior Vice President of Finance & Chief Financial Officer
|